Literature DB >> 11300316

Neuro-oncology clinical trials: promise and pitfalls.

M R Gilbert.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11300316     DOI： 10.1093/oxfordjournals.annonc.a000239

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme.

Authors:  Susan L Chua; Mark A Rosenthal; Shirley S Wong; David M Ashley; Anne-Marie Woods; Anthony Dowling; Lawrence M Cher
Journal:  Neuro Oncol       Date:  2004-01       Impact factor: 12.300
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.